Oxaliplatin-based neoadjuvant chemoradiation for locally advanced rectal cancer

被引：0
|
作者：
Kazmi, S. S. [1 ]
Azfar, M. [1 ]
Syed, A. A. [1 ]
Yusuf, M. A. [1 ]
机构：
[1] Shaukat Khanum Mem Hosp & Res Ctr, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15102
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RESPONSE WITH OXALIPLATIN BASED NEOADJUVANT CHEMOTHERAPY BEFORE CHEMORADIATION IN LOCALLY ADVANCED RECTAL CANCER
    Kazmi, A. S.
    Ali, W. I.
    Syed, A. A.
    Yusuf, M. A.
    Hameed, S.
    Majeed, U.
    Shah, M. A.
    Haider, I.
    Jamshed, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S398 - S398
  • [2] Oxaliplatin-based regimen as neoadjuvant treatment for loccaly advanced rectal cancer
    Stanculeanu, D.
    Scheusan, R.
    Tache, A.
    Cringeanu, A.
    Mitulescu, D.
    Mitulescu, G.
    Toma, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 58 - 58
  • [3] NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED RECTAL CANCER
    Meireles, P.
    Fonte, D.
    Costa, A.
    Almeida, D.
    Reis Lima Marques, M.
    Sarmento, C.
    Rey, C.
    Pinto, G.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S396 - S396
  • [4] Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen
    Cai, Runkai
    Zhang, Jianwei
    Cai, Yue
    Wu, Zehua
    Hu, Huabin
    Xie, Xiaoyu
    Deng, Yanhong
    Cheng, Yi
    Zhang, Yuting
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Impact of Fluoropyrimidine and Oxaliplatin-based Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
    Okada, Yuka
    Ozawa, Tsuyoshi
    Hayama, Tamuro
    Ohno, Kohei
    Tsukamoto, Mitsuo
    Fukushima, Yoshihisa
    Shimada, Ryu
    Nozawa, Keijiro
    Matsuda, Keiji
    Hashiguchi, Yojiro
    IN VIVO, 2021, 35 (01): : 593 - 601
  • [6] Midcourse neoadjuvant chemoradiation for locally advanced rectal cancer.
    Ko, Sanghwa
    Oh, Nahmgun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer
    Fu, Xing-li
    Fang, Zheng
    Shu, Liang-hui
    Tao, Guo-qing
    Wang, Jian-qiang
    Rui, Zhi-lian
    Zhang, Yong-jie
    Tian, Zhi-qiang
    ONCOTARGET, 2017, 8 (21) : 34340 - 34351
  • [8] Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
    Leichman, Cynthia Gail
    McDonough, Shannon L.
    Smalley, Stephen R.
    Billingsley, Kevin G.
    Lenz, Heinz-Josef
    Beldner, Matthew A.
    Hezel, Aram F.
    Velasco, Mario R.
    Guthrie, Katherine A.
    Blanke, Charles D.
    Hochster, Howard S.
    CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E121 - E125
  • [9] Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer
    Lu, Jun-Yang
    Xiao, Yi
    Qiu, Hui-Zhong
    Wu, Bin
    Lin, Guo-Le
    Xu, Lai
    Zhang, Guan-Nan
    Hu, Ke
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (04) : 213 - 219
  • [10] The immune phenotype of response to neoadjuvant chemoradiation in locally advanced rectal cancer
    Ball, Alasdair
    Wanigasooriya, Kasun
    Silva, Joao
    Beggs, Andrew
    BJS-BRITISH JOURNAL OF SURGERY, 2025, 112 : 13 - 13
12345